An IL-9–Pulmonary Macrophage Axis Defines the Allergic Lung Inflammatory Environment

The authors reported the identification of hepatitis C virus NS5A inhibitors Pibrentasvir and Ombitasvir as SARS-CoV-2 exonuclease inhibitors.